Albert Shu, MD
MSP Physician
Medicine
School of Medicine

Publications (3)

Top publication keywords:
MedicareHumansTreatment OutcomeAgedReoperationProportional Hazards ModelsArthroplasty, Replacement, HipFemaleMaleAged, 80 and overUnited StatesRisk FactorsProsthesis FailureHip ProsthesisIncidence

• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
  Science advances 2021 Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Donatelli J, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, …
• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
  medRxiv : the preprint server for health sciences 2021 Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, …
• Complications After Revision Total Hip Arthroplasty in the Medicare Population.
  The Journal of arthroplasty 2017 Badarudeen S, Shu AC, Ong KL, Baykal D, Lau E, Malkani AL